(FRPT) Freshpet - Overview
Sector: Consumer Defensive | Industry: Packaged Foods | Exchange: NASDAQ (USA) | Market Cap: 2.535m USD | Total Return: -38.6% in 12m
Avg Turnover: 96.0M
Qual. Beats: 0
Rev. Trend: 98.3%
Qual. Beats: 1
Warnings
Earnings expected to drop: P/E 13.5 → Forward 31.5
Share dilution 15.0% YoY
Choppy
Tailwinds
No distinct edge detected
Freshpet, Inc. (FRPT) specializes in the manufacturing and distribution of refrigerated, natural pet food and treats across North America and Europe. The company operates within the Packaged Foods & Meats sub-industry, primarily utilizing a proprietary network of branded refrigerators-known as Freshpet Fridges-to sell its products in retail locations such as grocery, mass, and pet specialty stores.
The business model relies on a cold-chain logistics infrastructure, which serves as a significant barrier to entry for traditional shelf-stable pet food competitors. This segment benefits from the humanization of pets trend, where consumers increasingly shift spending toward premium, fresh ingredients over processed kibble or canned goods.
Investors may find additional valuation metrics and performance data by reviewing the company profile on ValueRay. Freshpet continues to expand its manufacturing capacity and retail footprint to meet the rising demand for fresh-format pet nutrition.
- Freshpet Fridge placement expansion in retail stores drives long-term revenue growth
- Input cost volatility and logistics expenses impact overall gross profit margins
- Increased manufacturing capacity at Kitchens facilities scales production to meet demand
- Consumer shift toward premium fresh pet food accelerates market share gains
- Marketing efficiency and media spend effectiveness influence customer acquisition costs and profitability
| Net Income: 200.3m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.11 > 0.02 and ΔFCF/TA 11.46 > 1.0 |
| NWC/Revenue: 39.96% < 20% (prev 31.82%; Δ 8.14% < -1%) |
| CFO/TA 0.11 > 3% & CFO 196.1m > Net Income 200.3m |
| Net Debt (208.8m) to EBITDA (193.0m): 1.08 < 3 |
| Current Ratio: 6.18 > 1.5 & < 3 |
| Outstanding Shares: last quarter (56.1m) vs 12m ago 15.03% < -2% |
| Gross Margin: 38.90% > 18% (prev 0.41%; Δ 3.85k% > 0.5%) |
| Asset Turnover: 66.88% > 50% (prev 65.08%; Δ 1.81% > 0%) |
| Interest Coverage Ratio: 7.03 > 6 (EBITDA TTM 193.0m / Interest Expense TTM 14.2m) |
| A: 0.25 (Total Current Assets 541.8m - Total Current Liabilities 87.6m) / Total Assets 1.84b |
| B: -0.05 (Retained Earnings -94.2m / Total Assets 1.84b) |
| C: 0.06 (EBIT TTM 100.1m / Avg Total Assets 1.70b) |
| D: -0.16 (Book Value of Equity -94.6m / Total Liabilities 577.1m) |
| Altman-Z'' = 1.68 = BB |
| DSRI: 0.93 (Receivables 65.4m/62.7m, Revenue 1.14b/1.01b) |
| GMI: 1.04 (GM 38.90% / 40.57%) |
| AQI: 1.10 (AQ_t 0.05 / AQ_t-1 0.04) |
| SGI: 1.12 (Revenue 1.14b / 1.01b) |
| TATA: 0.00 (NI 200.3m - CFO 196.1m) / TA 1.84b) |
| Beneish M = -2.90 (Cap -4..+1) = A |
As of May 27, 2026, the stock is trading at USD 51.00 with a total of 1,927,001 shares traded.
Over the past week, the price has changed by +5.26%,
over one month by -22.08%,
over three months by -37.24% and
over the past year by -38.57%.
Freshpet has received a consensus analysts rating of 4.37. Therefore, it is recommended to buy FRPT.
- StrongBuy: 12
- Buy: 2
- Hold: 5
- Sell: 0
- StrongSell: 0
| Analysts Target Price | 82.4 | 61.5% |
P/E Trailing = 13.5381
P/E Forward = 31.5457
P/S = 2.2305
P/B = 2.0084
P/EG = 3.4782
Revenue TTM = 1.14b USD
EBIT TTM = 100.1m USD
EBITDA TTM = 193.0m USD
Long Term Debt = 397.9m USD (from longTermDebt, last quarter)
Short Term Debt = 4.68m USD (from shortTermDebt, last quarter)
Debt = 590.2m USD (from shortLongTermDebtTotal, last quarter) + Leases 96.2m
Net Debt = 208.8m USD (calculated: Debt 590.2m - CCE 381.4m)
Enterprise Value = 2.74b USD (2.53b + Debt 590.2m - CCE 381.4m)
Interest Coverage Ratio = 7.03 (Ebit TTM 100.1m / Interest Expense TTM 14.2m)
EV/FCF = 14.07x (Enterprise Value 2.74b / FCF TTM 195.0m)
FCF Yield = 7.11% (FCF TTM 195.0m / Enterprise Value 2.74b)
FCF Margin = 17.16% (FCF TTM 195.0m / Revenue TTM 1.14b)
Net Margin = 17.63% (Net Income TTM 200.3m / Revenue TTM 1.14b)
Gross Margin = 38.90% ((Revenue TTM 1.14b - Cost of Revenue TTM 694.3m) / Revenue TTM)
Gross Margin QoQ = 40.54% (prev 36.75%)
Tobins Q-Ratio = 1.49 (Enterprise Value 2.74b / Total Assets 1.84b)
Interest Expense / Debt = 2.41% (Interest Expense 14.2m / Debt 590.2m)
Taxrate = 26.10% (17.1m / 65.6m)
NOPAT = 74.0m (EBIT 100.1m * (1 - 26.10%))
Current Ratio = 6.18 (Total Current Assets 541.8m / Total Current Liabilities 87.6m)
Debt / Equity = 0.47 (Debt 590.2m / totalStockholderEquity, last quarter 1.26b)
Debt / EBITDA = 1.08 (Net Debt 208.8m / EBITDA 193.0m)
Debt / FCF = 1.07 (Net Debt 208.8m / FCF TTM 195.0m)
Total Stockholder Equity = 1.18b (last 4 quarters mean from totalStockholderEquity)
RoA = 11.79% (Net Income 200.3m / Total Assets 1.84b)
RoE = 15.72% (Net Income TTM 200.3m / Total Stockholder Equity 1.27b)
RoCE = 5.99% (EBIT 100.1m / Capital Employed (Equity 1.27b + L.T.Debt 397.9m))
RoIC = 4.28% (NOPAT 74.0m / Invested Capital 1.73b)
WACC = 7.30% (E(2.53b)/V(3.12b) * Re(8.58%) + D(590.2m)/V(3.12b) * Rd(2.41%) * (1-Tc(0.26)))
Discount Rate = 8.58% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: 64.44 | Cagr: 5.32%
[DCF] Terminal Value 75.44% ; FCFF base≈195.0m ; Y1≈195.8m ; Y5≈207.4m
[DCF] Fair Price = 61.39 (EV 3.23b - Net Debt 208.8m = Equity 3.02b / Shares 49.1m; r=8.35% [WACC [floored]]; 5y FCF grow 0.0% → 2.50% )
EPS Correlation: N/A | EPS CAGR: N/A | SUE: -0.01 | # QB: 0
Revenue Correlation: 98.29 | Revenue CAGR: 21.26% | SUE: 1.56 | # QB: 1
EPS current Quarter (2026-06-30): EPS=0.23 | Chg30d=+9.13% | Revisions=+33% | Analysts=3
EPS next Quarter (2026-09-30): EPS=0.37 | Chg30d=-1.82% | Revisions=-33% | Analysts=3
EPS current Year (2026-12-31): EPS=1.58 | Chg30d=+15.70% | Revisions=-14% | GrowthEPS=-44.2% | GrowthRev=+9.7%
EPS next Year (2027-12-31): EPS=1.90 | Chg30d=-5.46% | Revisions=-43% | GrowthEPS=+20.8% | GrowthRev=+9.0%
[Analyst] Revisions Ratio: -43%